RESUMEN
Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogeneic hematopoietic stem-cell transplantation (HSCT). We show herein that primary in vitro stimulation of CD45RA-selected CD4 T cells of stem-cell donors with 10/10 HLA-matched AML blasts results in expansion of cytolytic T-lymphocytes (CTL) that almost all recognize HLA-DPB1 mismatch alleles, which clinically occur in up to 80% of donor-patient pairs. Primary AML blasts were found to strongly express HLA-DPB1, whereas fibroblasts and keratinocytes used as surrogate target cells for graft-versus-host disease did express HLA-DPB1 only upon IFN-γ pre-treatment. Since patients' AML blasts are rarely available in clinical routine, we developed a protocol based on stimulation of donor-derived CD45RA-selected CD4 T cells with autologous dendritic cells electroporated with RNA encoding patients' HLA-DPB1 mismatch alleles. Short-term stimulated T cell-lines specifically lysed HLA-DPB1 mismatch-expressing AML blasts, but not fibroblasts and keratinocytes without IFN-γ pre-treatment. Notably, these CD4 CTL efficiently eliminated AML blasts upon adoptive transfer into leukemia-engrafted NSG mice. In conclusion, we show strong immunogenicity of HLA-DPB1 mismatch alleles in CD45RA-selected CD4 T cells of stem-cell donors and introduce a novel strategy to reliably generate HLA-DPB1-specific CD4 CTL that might be powerful cellular therapeutics in relapsed or refractory AML after HSCT.
Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Cadenas beta de HLA-DP/inmunología , Inmunoterapia , Leucemia/inmunología , Leucemia/terapia , Alelos , Animales , Linfocitos T CD4-Positivos/metabolismo , Citotoxicidad Inmunológica/genética , Citotoxicidad Inmunológica/inmunología , Femenino , Genotipo , Cadenas beta de HLA-DP/genética , Cadenas beta de HLA-DP/metabolismo , Trasplante de Células Madre Hematopoyéticas , Humanos , Inmunoterapia Adoptiva , Leucemia/genética , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/inmunología , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/patología , Activación de Linfocitos/genética , Activación de Linfocitos/inmunología , Ratones , Donantes de Tejidos , Trasplante HomólogoRESUMEN
Depletion of naive T cells from donor leukapheresis products (LPs) aims at the reduction of alloreactivity, while preserving memory T-cell reactivity (for example, to pathogens). This study established the immunomagnetic depletion procedure under clean room conditions using CD45RA beads and analyzed LPs of six donors for cell composition and functional immune responses. CD45RA depletion resulted in 3.4-4.7 log (median 4.4) reduction of CD45RA(+) T cells, thereby eliminating naive and late effector T cells. B cells were also completely removed, whereas significant proportions of NK cells, monocytes and granulocytes persisted. CD45RA-depleted LPs contained effector and central memory CD4(+) and CD8(+) T cells that showed sustained IFN-γ secretion to CMV, EBV, Aspergillus and Candida Ags. Alloreactivity was measured in MLRs between donors with complete HLA-mismatch. Alloreactive CD8(+) T cells were strongly reduced (median >1-log) upon CD45RA depletion, whereas alloreactive CD4(+) T cells persisted in significant numbers. In conclusion, clinical grade depletion of CD45RA(+) naive T cells from donor LPs is feasible and highly efficient. The depleted products show sustained CD4(+) and CD8(+) T-cell reactivity to pathogens and effectively reduced CD8-mediated alloreactivity. Prophylactic and preemptive infusions after allogeneic SCT may improve T-cell reconstitution and pathogen-specific immunosurveillance, along with lower risk of inducing GVHD.
Asunto(s)
Enfermedad Injerto contra Huésped/prevención & control , Separación Inmunomagnética/métodos , Antígenos Comunes de Leucocito/metabolismo , Depleción Linfocítica/métodos , Linfocitos T/inmunología , Adulto , Antígenos de Neoplasias/metabolismo , Aspergillus , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Candida , Citomegalovirus , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Herpesvirus Humano 4 , Humanos , Inmunofenotipificación , Interferón gamma/metabolismo , Leucaféresis/métodos , Depleción Linfocítica/instrumentación , MasculinoRESUMEN
Adoptive immunotherapy with tumour-reactive CD8(+) cytotoxic T lymphocytes (CTLs) requires efficient in vitro approaches allowing the expansion of CTLs to large numbers prior infusion. Here, we investigated the antigen-independent activation and the expansion of human T cells in peripheral blood mononuclear cells (PBMCs) and in tumour-reactive CTLs using Dynabeads coated with monoclonal antibodies to CD3 and to the costimulatory molecules CD28 and CD137 (4-1BB). T cells in PBMCs showed an increased expansion rate of 15- to 17-fold during a 2-week culture period using antibody-conjugated beads with interleukin-2 (IL-2) added versus IL-2 alone. No significant difference between CD3/CD28 beads and CD3/CD28/CD137 beads was observed (P = 0.4). In contrast, expansion of tumour-reactive CD8(+) CTLs over 2 weeks was more efficient using CD3/CD28/CD137 beads (14.4-fold ± 1.2) compared with CD3/CD28 beads (10.6-fold ± 0.7) (P = 0.03) and matched well to the control arm using weekly stimulation with tumour cells. Although all modes of in vitro stimulation decreased the expression of central memory markers CD62L and CCR7 on CTLs, bead-activated cultures expressed consistently higher levels than tumour-stimulated cultures. CTLs analysed after bead-induced expansion versus weekly tumour stimulation showed equal IFN-γ production in ELISPOT assay. Furthermore, cytotoxicity assays demonstrated an either unchanged or slightly reduced capability of tumour cell lysis for antigen-independent stimulated CTLs versus those that maintained on weekly tumour stimulation, regardless of which type of beads was used. Our data suggest that the conjugation of anti-CD137 antibodies to conventional CD3/CD28 beads results in a minor but significant increase in the expansion capacity for tumour-reactive CD8(+) CTLs.
Asunto(s)
Antígenos CD28/inmunología , Complejo CD3/inmunología , Inmunoterapia Adoptiva/métodos , Activación de Linfocitos/inmunología , Neoplasias/inmunología , Linfocitos T Citotóxicos/inmunología , Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/inmunología , Células Cultivadas , Humanos , Separación Inmunomagnética , Interferón gamma/biosíntesis , Interferón gamma/inmunología , Interleucina-2/inmunología , Selectina L/inmunología , Receptores CCR7/inmunologíaRESUMEN
Dendritic cells (DCs) are key players in eliciting immunity against antigens, therefore making them the focus of many investigations on immune responses in infections, cancer and autoimmune diseases. Nanosized materials have just recently been investigated for their use as carriers of antigens and as labeling agents for DCs. For this later use nanoparticles should be non-toxic and should most importantly not alter the physiological functions of DCs. Here we demonstrate that by the use of polymeric fluorescent nanoparticles as synthesized by the miniemulsion process immature DCs (iDCs) can be efficiently labeled intracellularly. Amino functionalized nanoparticles are more effective than carboxy functionalized ones. Even after 8 days 95% of DCs have retained nanoparticles with a fluorescence intensity of 67% compared to day 1. Nanoparticle labeling does not influence expression of cell surface molecules on mature DCs (mDCs) like HLA-DR, CD80/83/86, CCR7, CD11c nor does it influence the immunostimulatory capacity of mDCs. This procedure does also not impair the capability of DCs for uptake, processing and presentation of viral antigens as demonstrated by interferon-gamma ELISPOT on T cells stimulated with viral antigens presented by DCs. Therefore polymeric nanoparticles are a promising tool to study migration and homing of DCs in animal studies.
Asunto(s)
Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Nanopartículas/química , Poliestirenos/química , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/microbiología , Células Cultivadas , Células Dendríticas/efectos de los fármacos , Citometría de Flujo , Humanos , Microscopía Confocal , Nanopartículas/efectos adversosRESUMEN
Acute graft-versus-host disease (aGVHD) is a life-threatening complication after solid-organ transplantation, which is mediated by host-reactive donor T cells emigrating from the allograft. We report on two liver transplant recipients who developed an almost complete donor chimerism in peripheral blood and bone marrow-infiltrating T cells during aGVHD. By analyzing these T cells directly ex vivo, we found that they died by apoptosis over time without evidence of rejection by host T cells. The host-versus-donor reactivity was selectively impaired, as anti-third-party and antiviral T cells were still detectable in the host repertoire. These findings support the acquired donor-specific allotolerance concept previously established in animal transplantation studies. We also observed that the resolution of aGVHD was not accompanied by an expansion of circulating immunosuppressive CD4/CD25/FoxP3-positive T cells. In fact, graft-versus-host-reactive T cells were controlled by an alternative negative regulatory pathway, executed by the programmed death (PD)-1 receptor and its ligand PD-L1. We found high PD-1 expression on donor CD4 and CD8 T cells. In addition, blocking PD-L1 on host-derived cells significantly enhanced alloreactivity by CD8 T cells in vitro. We suggest the interference with the PD-1/PD-L1 pathway as a therapeutic strategy to control graft-versus-host-reactive T cells in allograft recipients.
Asunto(s)
Antígenos CD/metabolismo , Antígenos de Superficie/metabolismo , Proteínas Reguladoras de la Apoptosis/metabolismo , Linfocitos T CD8-positivos/metabolismo , Regulación de la Expresión Génica , Enfermedad Injerto contra Huésped/sangre , Trasplante de Hígado/métodos , Animales , Linfocitos T CD4-Positivos/metabolismo , Trasplante de Células , Factores de Transcripción Forkhead/biosíntesis , Enfermedad Injerto contra Huésped/diagnóstico , Humanos , Inmunosupresores/uso terapéutico , Subunidad alfa del Receptor de Interleucina-2/biosíntesis , Masculino , Ratones , Ratones Noqueados , Persona de Mediana Edad , Receptor de Muerte Celular Programada 1RESUMEN
The morphology and deformability of erythrocytes and the lipid composition of the blood plasma and red cells were studied in rabbits during a diet with 1% cholesterol. After 2 weeks of diet the concentration of the atherogenic lipid lysophosphatidylcholine was significantly increased. 25% of the erythrocytes had an abnormal shape (echinocytes) and the viscosity was increased at the lower shear rates of 0.1-1/s. The shape transformation of the erythrocytes was in vitro after 2 weeks spontaneously reversible, but not after 10 weeks of diet. After 10 weeks the deformability of the erythrocytes was reduced, whereas it was normal before, despite the altered cell shape and the increased low-shear viscosity. It is concluded that the pathophysiological significance of echinocytes does not originate from a diminished deformability as reported before.
Asunto(s)
Colesterol en la Dieta/farmacología , Eritrocitos/citología , Animales , Viscosidad Sanguínea/efectos de los fármacos , Recuento de Eritrocitos , Eritrocitos/efectos de los fármacos , Femenino , Hematócrito , Hemoglobinas/análisis , Conejos , Reología , Factores de TiempoRESUMEN
This manuscript reviews the literature on hydrogen metabolism in blue-green algae and reports some new data from this laboratory. H2-formation by intact cells is found to be catalyzed exclusively by nitrogenase. Its rate appears to be variable from strain to strain used byt is--in our hands--very small. Therefore, blue-green algae are presumably of limited value in projects of solar energy conversion to form molecular hydrogen. These organisms are also able to consume the gas in a reaction catalysed by hydrogenase. Hydrogen is mainly consumed in an oxygen dependent reaction, as in aerobic nitrogen fixing bacteria. It can also serve as an electron donor for nitrogen fixation under certain physiological conditions. In experiments with a cell-free preparation, hydrogenase is found to be membrane-bound. The enzyme is characterized with respect to its specifity towards electron donors and acceptors.